Articles

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

Cannabinoid Treatment for Fibromyalgia Symptom Management: Results from a Case Series

California’s bill creating new restrictions on intoxicating hemp products has prompted responses citing negative impacts on patients and businesses.

California Hemp Bill Faces Opposition from Retailers and Medical Professionals

This month’s webinar discussed studies conducted on cannabis and psychedelics for various conditions including anxiety and autism spectrum disorder.

Advancements in Cannabis Research: Insights from Healer’s July 2024 Webinar

Brian C. Smith, PhD, is Founder, CEO, and Chief Technical Officer of Big Sur Scientific. He is the inventor of the BSS series of patented mid-infrared based cannabis analyzers. Dr. Smith has done pioneering research and published numerous peer-reviewed papers on the application of mid-infrared spectroscopy to cannabis analysis, and sits on the editorial board of Cannabis Science and Technology. He has worked as a laboratory director for a cannabis extractor, as an analytical chemist for Waters Associates and PerkinElmer, and as an analytical instrument salesperson. He has more than 30 years of experience in chemical analysis and has written three books on the subject. Dr. Smith earned his PhD on physical chemistry from Dartmouth College. Direct correspondence to: 

Here, we discuss the importance of calibration metrics and how to measure calibration quality.

Calibration Science, Part IV: Calibration Metrics

This review highlights an in-silico assessment of the binding interactions of pro-drug moiety analogs and an importance in identifying potential issues that would need further testing to ensure safety for consumers such as the hERG values which are pertinent in the pharmaceutical fields in whether or not drugs can be safe to use.


Cannabinoid Ethers: Identification, Binding Interactions, and their ADME Properties

Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.

CBD vs. THC: Exploring the Differences and Potential Benefits

This month’s Healer webinar discussed several studies on cannabis and symptoms of dementia and cognitive decline.

Cannabis and Dementia Symptoms: Healer Webinar Examines Relevant Research 

This article discusses the early experiments and studies on the effects of two cannabinoids on anxiety.

CBD vs THC: The Great Anxiety Debate

As markets mature, manufacturing terpene blends have become a new art form and a differentiating factor for potential therapeutic applications. Here, we dive deeper into the insights of terpene formulation considerations.

Considerations  for Formulating  Extracts with Terpenes

In this blog installment, we take a deep dive into research on how cannabis affects neurodegenerative disorders such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.